R1

MS Has Learnt to Stop Inflammation. It Still Cannot Repair the Damage.

Resistant hypertension may need a diagnostic revolution, not just another drug

When diabetes tech fails, personalised care fails with it

AI genomics market set to hit $9.3B by 2030, but regulation and equity gaps remain unresolved

For Drug-Resistant Epilepsy, Surgery Should Not Be the Only Door

Gonorrhoea Is Not Disappearing. Too Many Systems Are Failing to See It.

Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.

The Biomarker Test Cannot Wait Until Relapse

Gene therapy is entering cardiology. Friedreich ataxia shows why rare heart disease may be the first test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
